Literature DB >> 35306791

Expanding the Clinical Spectrum of RFC1 Gene Mutations.

Dinkar Kulshreshtha1, Jacky Ganguly1, Mandar Jog1.   

Abstract

Biallelic intronic repeat expansion in the replication factor complex unit 1 (RFC1) gene has recently been described as a cause of late onset ataxia with degeneration of the cerebellum, sensory pathways and the vestibular apparatus. This condition is termed cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS). Since the identification of this novel gene mutation, the phenotypic spectrum of RFC1 mutations continues to expand and includes not only CANVAS but also slowly progressive cerebellar ataxia, ataxia with chronic cough (ACC), isolated sensory neuropathy and multisystemic diseases. We present a patient with a genetically confirmed intronic repeat expansion in the RFC1 gene with a symptom complex not described previously.

Entities:  

Keywords:  Ataxia; CANVAS; RFC1

Year:  2022        PMID: 35306791      PMCID: PMC9171309          DOI: 10.14802/jmd.21117

Source DB:  PubMed          Journal:  J Mov Disord        ISSN: 2005-940X


The term ‘cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS)’ was coined in 2011 for the combination of late onset cerebellar ataxia, sensory neuropathy and vestibular syndrome [1-3]. The majority of these patients have a characteristic impairment of visually enhanced vestibulo-ocular reflex (VVOR) and peripheral sensory neuropathy [4]. Sensory abnormalities on electrophysiological testing have been identified in 100% of patients with genetically confirmed CANVAS [5]. Our patient presented with a history of unsteadiness and incoordination with no sensory findings and a normal sensory nerve conduction study. The VVOR was preserved as well. However, prior history was suggestive of vestibulopathy and characteristic imaging findings revealed evidence of underlying RFC1 gene mutations.

CASE REPORT

A sixty-six-year-old female with normal perinatal and developmental history presented with progressive gait unsteadiness for the last 6 years. There was a significant past history of episodic imbalance and dizziness for many years, and the patient was diagnosed with benign paroxysmal positional vertigo, which improved on vestibular physiotherapy. No significant family history was noted (Figure 1). Her symptoms progressed with upper limb incoordination and slurring of speech for the last two years. Examination revealed a Montreal Cognitive Assessment (MoCA) score of 25/30. The eye movements were minimally affected with gaze-evoked nystagmus and mild saccadic overshoot. The head impulse test (HIT) was negative, and the VVOR was well preserved (Supplementary Video 1 in the online-only Data Supplement). Axial and appendicular cerebellar signs were present. The sensory and motor examination was normal, and reflexes were preserved (Supplementary Video 2 in the online-only Data Supplement). Bedside testing for autonomic functions was normal. Her routine blood tests and nerve conduction studies (including sensory nerve action potentials) were normal. Magnetic resonance imaging (MRI) of the brain showed cerebellar atrophy largely restricted to Crus 1 and 2 of the cerebellum (Figure 2). The brain stem was normal, and the ‘hot cross bun’ and the ‘putaminal rim sign’ of multiple system atrophy (MSA) were absent. The spinocerebellar ataxia (SCA) gene panel, including SCA6 (CACNA1A), the spastic paraplegia gene panel (SPG panel including SPG7), Friedreich’s ataxia gene (frataxin) testing, the autoimmune and paraneoplastic panel, and vitamin E and tissue transglutaminase (TTG) (IgA anti TTG) testing were all negative. Despite normal nerve conduction studies and VVOR being preserved, imaging characteristics suggesting CANVAS prompted us to order a repeat expansion test for the RFC1 gene. A biallelic intronic AAGGG pathogenic repeat expansion (460 repeats) was identified. Repeat sizing was performed by standard flanking PCR (F-PCR) and repeat primed PCR (RP-PCR) followed by capillary electrophoresis. The expansion differed in both size and nucleotide sequence from the reference AAAAG allele.
Figure 1.

Pedigree of the affected family. There was no similar illness in the family.

Figure 2.

Brain magnetic resonance imaging of the patient with a RFC1 gene mutation. T2WI (A and B) shows relatively preserved cerebellar hemispheres with prominent vermian atrophy. Sagittal (C) and parasagittal (D) FLAIR sequences show classical atrophy restricted to lobules VI, VIIA and VIIB of the cerebellum. T2WI, T2 weighted image; FLAIR, fluid-attenuated inversion recovery.

DISCUSSION

CANVAS syndrome is a recent addition to the group of degenerative ataxias. In 2004, Migliaccio et al. [6] described four patients with slowly progressive cerebellar ataxia with bilateral vestibulopathy. Three of these patients had evidence of sensory neuropathy on electrophysiological testing. The genetic evaluation was negative for SCA 1, 2, 3, 6, and 7 and Friedreich’s ataxia, and the clinical and radiological presentation did not suggest MSA. Thus, the condition was termed cerebellar ataxia with bilateral vestibulopathy (CABV) [6]. Szmulewicz et al. [3] observed that all eighteen subjects with CABV had neuropathy in which the sensory nerve action potentials was not recordable. Length-dependent peripheral neuropathy dominated the clinical picture, and few patients had global sensory deficits. The complete clinical presentation of cerebellar ataxia, vestibulopathy and sensory neuropathy was termed CANVAS [3]. Cortese et al. [1] identified a biallelic AAGGG repeat expansion in the RFC1 gene in 90% of DNA samples with the CANVAS phenotype and 14% of DNA samples in other adult-onset ataxias. Their patient cohort had symptoms of cerebellar dysfunction, sensory neuropathy, oscillopsia due to impaired vestibulo-ocular reflex and mild autonomic dysfunction (postural hypotension, constipation, urogenital dysfunction and anhidrosis). A long-standing history of chronic cough preceding symptom onset by 2–3 decades was seen in 64/105 patients who tested positive for RFC1 mutations [1]. In twenty-three CANVAS patients, 93% had at least two autonomic symptoms, with electrophysiological evidence of sympathetic or parasympathetic dysfunction seen in 83% of patients [7]. Thus, CANVAS is an important differential in suspected MSA, although vestibulopathy and prominent sensory neuropathy favor a diagnosis of CANVAS. Similarly, sensory neuropathy/neuronopathy is an essential feature of the CANVAS complex. An abnormal sensory nerve conduction study was reported in all patients by Cortese et al. [1]. Postmortem studies in CANVAS cases have shown dorsal root ganglionopathy and secondary degeneration of central and peripheral sensory axons [8]. However, a substantial proportion of CANVAS patients have preserved stretch reflexes. Infante et al. [9] postulated that the relative sparing of the type 1a fibers subserving the muscle spindle afferents is responsible for the normal reflexes despite widespread neuropathy. Likewise, spasmodic cough is thought to be secondary to impaired C-fiber-mediated sensory innervation of the upper airways and esophagus, causing denervation hypersensitivity of the secondary neurons in the nucleus solitarius [9]. Impairment of the VVOR is suggestive of vestibulopathy with cerebellar dysfunction. In isolated vestibulopathy, the smooth pursuits (SP) and optokinetic reflexes (OKR) are preserved and compensate for the abnormal vestibulo-ocular reflex (VOR). However, in cerebellar dysfunction, the VOR compensates for the abnormal SP and OKR to maintain the VVOR [6]. Impaired VVOR is clinically demonstrated by turning the head slowly while the gaze is maintained at an earth-fixed target. The compensatory eye movements in CANVAS are saccadic rather than smooth, thereby localizing the abnormality to both the cerebellar and vestibular systems [10]. Traschütz et al. [2] reported that visual compensation, sensory symptoms, and cough are strong determinants of RFC1-positive patients. Another radiological clue to diagnosing CANVAS, as seen in our patient, is the characteristic brain imaging findings. In fifty-six RFC1-positive patients, vermian atrophy was the most consistent finding, as it is seen in approximately 80% of patients, which is more frequent than cerebellar atrophy. Anterior and dorsal vermian involvement occur in lobules VI, VIIA and VIIB, and the hemispheric atrophy in the posterosuperior and horizontal fissures occur in Crus 1 of the cerebellum [4]. Brain stem atrophy, primarily affecting the pons and mid brain, was seen in 13% of cases and was associated with a longer disease duration and worsening eye movement abnormalities [2]. Nonspecific supratentorial abnormalities or cerebral atrophy were seen in 19% of RFC1-positive patients [5]. Our patient did not have any pontine atrophy or any cerebral atrophy disproportionate to her age. This patient with RFC1 biallelic expansion had pure cerebellar ataxia and a prior history of vestibular dysfunction with a normal sensory examination, both clinically and on electrophysiology. She also had a preserved VVOR with no suggestion of autonomic dysfunction or chronic cough. There was no clinical evidence suggesting CANVAS; however, the characteristic MRI finding was a strong indication for RFC1 genetic testing. Thus, in the absence of sensory involvement and preserved VVOR, which are prerequisites to CANVAS, the vermian atrophy (Crus 1) observed by MRI in patients with degenerative ataxias calls for RFC1 gene testing. This novel presentation further expands the phenotypic spectrum related to the RFC1 gene. Testing for RFC1 repeat expansion is important in patients with typical and atypical CANVAS phenotypes, including those with idiopathic sensory neuropathy, ataxia with chronic cough or idiopathic slowly progressive degenerative ataxias.
  10 in total

Review 1.  Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS): a review of the clinical features and video-oculographic diagnosis.

Authors:  David J Szmulewicz; John A Waterston; Hamish G MacDougall; Stuart Mossman; Andrew M Chancellor; Catriona A McLean; Saumil Merchant; Peter Patrikios; G Michael Halmagyi; Elsdon Storey
Journal:  Ann N Y Acad Sci       Date:  2011-09       Impact factor: 5.691

2.  Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS.

Authors:  David J Szmulewicz; Catriona A McLean; Michael L Rodriguez; Andrew M Chancellor; Stuart Mossman; Duncan Lamont; Leslie Roberts; Elsdon Storey; G Michael Halmagyi
Journal:  Neurology       Date:  2014-03-28       Impact factor: 9.910

3.  Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome.

Authors:  D J Szmulewicz; J A Waterston; G M Halmagyi; S Mossman; A M Chancellor; C A McLean; E Storey
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

4.  Cerebellar ataxia with bilateral vestibulopathy: description of a syndrome and its characteristic clinical sign.

Authors:  Americo A Migliaccio; G Michael Halmagyi; Leigh A McGarvie; Phillip D Cremer
Journal:  Brain       Date:  2003-11-07       Impact factor: 13.501

5.  Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) with chronic cough and preserved muscle stretch reflexes: evidence for selective sparing of afferent Ia fibres.

Authors:  Jon Infante; Antonio García; Karla M Serrano-Cárdenas; Rocío González-Aguado; José Gazulla; Enrique M de Lucas; José Berciano
Journal:  J Neurol       Date:  2018-04-25       Impact factor: 4.849

6.  Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia 'CANVAS' syndrome.

Authors:  Teddy Y Wu; Jennifer M Taylor; Dean H Kilfoyle; Andrew D Smith; Ben J McGuinness; Mark P Simpson; Elizabeth B Walker; Peter S Bergin; James C Cleland; David O Hutchinson; Neil E Anderson; Barry J Snow; Tim J Anderson; Laura A F Paermentier; Nick J Cutfield; Andrew M Chancellor; Stuart S Mossman; Richard H Roxburgh
Journal:  Brain       Date:  2014-07-28       Impact factor: 13.501

7.  Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia.

Authors:  Roisin Sullivan; Jana Vandrovcova; Mary M Reilly; Andrea Cortese; Roberto Simone; Huma Tariq; Wai Yan Yau; Jack Humphrey; Zane Jaunmuktane; Prasanth Sivakumar; James Polke; Muhammad Ilyas; Eloise Tribollet; Pedro J Tomaselli; Grazia Devigili; Ilaria Callegari; Maurizio Versino; Vincenzo Salpietro; Stephanie Efthymiou; Diego Kaski; Nick W Wood; Nadja S Andrade; Elena Buglo; Adriana Rebelo; Alexander M Rossor; Adolfo Bronstein; Pietro Fratta; Wilson J Marques; Stephan Züchner; Henry Houlden
Journal:  Nat Genet       Date:  2019-03-29       Impact factor: 38.330

8.  Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease.

Authors:  Andreas Traschütz; Andrea Cortese; Selina Reich; Natalia Dominik; Jennifer Faber; Heike Jacobi; Annette M Hartmann; Dan Rujescu; Solveig Montaut; Andoni Echaniz-Laguna; Sevda Erer; Valerie Cornelia Schütz; Alexander A Tarnutzer; Marc Sturm; Tobias B Haack; Nadège Vaucamps-Diedhiou; Helene Puccio; Ludger Schöls; Thomas Klockgether; Bart P van de Warrenburg; Martin Paucar; Dagmar Timmann; Ralf-Dieter Hilgers; Jose Gazulla; Michael Strupp; German Moris; Alessandro Filla; Henry Houlden; Mathieu Anheim; Jon Infante; A Nazli Basak; Matthis Synofzik
Journal:  Neurology       Date:  2021-01-25       Impact factor: 9.910

Review 9.  Update on Cerebellar Ataxia with Neuropathy and Bilateral Vestibular Areflexia Syndrome (CANVAS).

Authors:  Mathieu Dupré; Ruben Hermann; Caroline Froment Tilikete
Journal:  Cerebellum       Date:  2020-10-04       Impact factor: 3.847

10.  Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion.

Authors:  Andrea Cortese; Stefano Tozza; Wai Yan Yau; Salvatore Rossi; Sarah J Beecroft; Zane Jaunmuktane; Zoe Dyer; Gianina Ravenscroft; Phillipa J Lamont; Stuart Mossman; Andrew Chancellor; Thierry Maisonobe; Yann Pereon; Cecile Cauquil; Silvia Colnaghi; Giulia Mallucci; Riccardo Curro; Pedro J Tomaselli; Gilbert Thomas-Black; Roisin Sullivan; Stephanie Efthymiou; Alexander M Rossor; Matilde Laurá; Menelaos Pipis; Alejandro Horga; James Polke; Diego Kaski; Rita Horvath; Patrick F Chinnery; Wilson Marques; Cristina Tassorelli; Grazia Devigili; Lea Leonardis; Nick W Wood; Adolfo Bronstein; Paola Giunti; Stephan Züchner; Tanya Stojkovic; Nigel Laing; Richard H Roxburgh; Henry Houlden; Mary M Reilly
Journal:  Brain       Date:  2020-02-01       Impact factor: 15.255

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.